A Phase II, Single Arm, Multicentre Trial to Determine the Efficacy and Safety of CTL019 in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
This is a multi-centre, phase II study to determine the efficacy and safety of CTL019 in
adult patients with relapsed or refractory DLBCL.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society